3Dufour DR.Assessment of liver fibrosis;can serum become the sample of choice?.Clin Chem,2005,51:1763-1764.
4Macwell PR,Flisiak R.Change in serological biomarkers of liver function and connective tissue turn over in chronic hepatitis B during Iamivudine therapy.Biomarkers,2005,10:475-484.
9Walsh KM,Timms P,Campbell S.et al. Plasma levels of M MP-2 and TIMP-1 and TIMP-2 as noninvasive markers of liver disease in chronic hepatitis C :comparison using ROC analysis[J]. Dig Dis Sci,1999,44(3) :624.
10Ninoniya T, Yoon S, Hayashi Y.et al. Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic C patient treated with interferon-alpha histological evaluation by a modified histology ic al activity index scoring system[J]. J Gastroenterol Hepatol,1998,13(1) :68.
